Is Medicare's new functional equivalence standard fair?

CMS' ruling that Aranesp and Procrit are functionally equivalent so they should get the same reimbursement is creating a stir among drug companies which feel that one product has more advantages than the other and should deserve more payment.

Related Videos
© 2023 MJH Life Sciences

All rights reserved.